Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25962811)

Published in Cancer Epidemiol Biomarkers Prev on May 11, 2015

Authors

Eleanor Kane1, Christine F Skibola2, Paige M Bracci3, James R Cerhan4, Laura Costas5, Karin Ekström Smedby6, Elizabeth A Holly3, Marc Maynadié7, Anne J Novak4, Tracy J Lightfoot8, Stephen M Ansell4, Alex G Smith8, Mark Liebow4, Mads Melbye9, Lindsay Morton10, Silvia de Sanjosé5, Susan L Slager4, Sophia S Wang11, Yawei Zhang12, Tongzhang Zheng12, Eve Roman8

Author Affiliations

1: Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom. eleanor.kane@ecsg.york.ac.uk.
2: Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, Alabama.
3: Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
4: Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
5: Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, and CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
6: Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
7: Biological Hematology Unit, CRB Ferdinand Cabanne, University Hospital of Dijon and University of Burgundy, France.
8: Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, United Kingdom.
9: Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
10: Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.
11: Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, California.
12: Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut.

Articles cited by this

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68

A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev (2007) 14.60

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood (2007) 4.31

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86

Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol (2007) 2.54

Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01

Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol (1999) 1.80

Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol (2009) 1.79

Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer (2003) 1.51

Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol (2008) 1.45

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet (2014) 1.41

Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol (2009) 1.40

Differential misclassification and the assessment of gene-environment interactions in case-control studies. Am J Epidemiol (1998) 1.27

Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control (2003) 1.26

Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol (2010) 1.21

Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control (2005) 1.20

Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18

Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet (2011) 1.17

Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol (2012) 1.17

Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors. Cancer Res (2007) 1.17

Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer (2011) 1.16

Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Haematologica (2008) 1.16

Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta (2010) 1.13

Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. Cytokine (2009) 1.09

Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr (2014) 1.08

Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol (2009) 1.06

Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. Eur Cytokine Netw (2011) 1.03

Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer (2006) 1.02

Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control (2004) 1.01

Overweight and obesity at different times in life as risk factors for non-Hodgkin's lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev (2008) 0.98

Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood (2010) 0.97

A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma. Cancer Prev Res (Phila) (2013) 0.97

Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer (2008) 0.96

B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci (2013) 0.96

Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer (2013) 0.95

Body mass index and risk of malignant lymphoma in Scandinavian men and women. J Natl Cancer Inst (2005) 0.94

Anthropometric factors, physical activity, and risk of non-Hodgkin's lymphoma in the Women's Health Initiative. Cancer Epidemiol (2011) 0.94

Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev (2013) 0.93

Body mass index, height and risk of lymphoid neoplasms in a large United States cohort. Leuk Lymphoma (2013) 0.92

Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring) (2011) 0.90

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood (2012) 0.89

A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cancer Epidemiol Biomarkers Prev (2012) 0.86

Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol (2012) 0.83

Association of anthropometric characteristics with the risk of malignant lymphoma and plasma cell myeloma in a Japanese population: a population-based cohort study. Cancer Epidemiol Biomarkers Prev (2010) 0.83

The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol (2012) 0.81

The molecular contribution of TNF-α in the link between obesity and breast cancer. Oncol Rep (2010) 0.81

Obesity and the Endometrium: Adipocyte-Secreted Proinflammatory TNF α Cytokine Enhances the Proliferation of Human Endometrial Glandular Cells. Obstet Gynecol Int (2013) 0.80

Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk (2013) 0.80

Dietary and lifestyle factors and risk of non-hodgkin's lymphoma in Oman. Asian Pac J Cancer Prev (2013) 0.79

Articles by these authors

Fever during pregnancy and motor development in children: a study within the Danish National Birth Cohort. Dev Med Child Neurol (2015) 2.01

Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma. Clin Cancer Res (2015) 2.00

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet (2010) 1.78

Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet (2012) 1.36

Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol (2015) 1.02

Decrease in vitamin D status in the Greenlandic adult population from 1987-2010. PLoS One (2014) 0.81

Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2014) 0.81

Associations between Vitamin D Status and Type 2 Diabetes Measures among Inuit in Greenland May Be Affected by Other Factors. PLoS One (2016) 0.80

A detailed family history of myocardial infarction and risk of myocardial infarction--a nationwide cohort study. PLoS One (2015) 0.79

Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev (2015) 0.78

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev (2015) 0.76

Improving vaccine safety through a better understanding of vaccine adverse events. Clin Infect Dis (2015) 0.76

Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Res (2016) 0.75

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma. Am J Hematol (2015) 0.75

Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects. PLoS One (2016) 0.75

Recurrence of Subdural Haematoma in a Population-Based Cohort - Risks and Predictive Factors. PLoS One (2015) 0.75

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma. Am J Hematol (2016) 0.75

Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia. Am J Hematol (2016) 0.75

Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol Biomarkers Prev (2015) 0.75

Filaggrin genotype and skin diseases independent of atopic dermatitis in childhood. Pediatr Allergy Immunol (2015) 0.75

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genet Epidemiol (2019) 0.75

Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study†. Eur Heart J (2015) 0.75

Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth. J Allergy Clin Immunol (2016) 0.75